Effects of fetal insulin secretory deficiency on metabolism in fetal lamb

Anthony F Philipps, T. S. Rosenkrantz, M. L. Grunnet, M. E. Connolly, P. J. Porte, J. R. Raye

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Fetal insulin secretion may be of importance in determining both fetal metabolic rate and glucose homeostasis in the resting state. To investigate this question, streptozocin (STZ) was injected into 10 late-gestation fetal lambs, and the effects of STZ on fetal pancreatic insulin storage and secretion, fetal metabolic rate, and umbilical glucose uptake were then studied. Fetal STZ injection caused a relative fetal hyperglycemia by 24 h after injection. Fetal hyperglycemia reached a maximum by 72 h and persisted for at least 10 days after injection. Neonates delivered after fetal injection were frankly diabetic. Fetal STZ injection was associated with complete suppression of both glucose- and tolbutamide-stimulated insulin release, although no changes in peripheral insulin concentration were observed when compared with controls. Fetal pancreatic insulin content was only 13% of that expected on the basis of gestational age. In a subgroup of 7 STZ-treated fetal lambs, fetal hyperglycemia was related to decrements in umbilical venoarterial difference of glucose, umbilical glucose uptake, and glucose-O2 quotient. No changes in maternal glucose homeostasis or in fetal O2 consumption were noted. The data suggest that deficient fetal insulin storage and secretion are associated with a decrement in exogenous fetal glucose entry but not in fetal metabolic rate. Whether the observed fetal changes relate to enhanced endogenous fetal glucose production with a passive decrease in maternofetal glucose transfer or are simply due to a decrease in overall fetal glucose utilization is not known. It is speculated that a quantitative decrease in pancreatic insulin secretion is responsible for the observed changes.

Original languageEnglish (US)
Pages (from-to)964-972
Number of pages9
JournalDiabetes
Volume35
Issue number9
StatePublished - 1986
Externally publishedYes

Fingerprint

Insulin
Glucose
Streptozocin
Umbilicus
Injections
Hyperglycemia
Homeostasis
Tolbutamide
Gestational Age
Mothers
Pregnancy

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Philipps, A. F., Rosenkrantz, T. S., Grunnet, M. L., Connolly, M. E., Porte, P. J., & Raye, J. R. (1986). Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes, 35(9), 964-972.

Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. / Philipps, Anthony F; Rosenkrantz, T. S.; Grunnet, M. L.; Connolly, M. E.; Porte, P. J.; Raye, J. R.

In: Diabetes, Vol. 35, No. 9, 1986, p. 964-972.

Research output: Contribution to journalArticle

Philipps, AF, Rosenkrantz, TS, Grunnet, ML, Connolly, ME, Porte, PJ & Raye, JR 1986, 'Effects of fetal insulin secretory deficiency on metabolism in fetal lamb', Diabetes, vol. 35, no. 9, pp. 964-972.
Philipps AF, Rosenkrantz TS, Grunnet ML, Connolly ME, Porte PJ, Raye JR. Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. Diabetes. 1986;35(9):964-972.
Philipps, Anthony F ; Rosenkrantz, T. S. ; Grunnet, M. L. ; Connolly, M. E. ; Porte, P. J. ; Raye, J. R. / Effects of fetal insulin secretory deficiency on metabolism in fetal lamb. In: Diabetes. 1986 ; Vol. 35, No. 9. pp. 964-972.
@article{0334308f44ba442188b2b923f221982c,
title = "Effects of fetal insulin secretory deficiency on metabolism in fetal lamb",
abstract = "Fetal insulin secretion may be of importance in determining both fetal metabolic rate and glucose homeostasis in the resting state. To investigate this question, streptozocin (STZ) was injected into 10 late-gestation fetal lambs, and the effects of STZ on fetal pancreatic insulin storage and secretion, fetal metabolic rate, and umbilical glucose uptake were then studied. Fetal STZ injection caused a relative fetal hyperglycemia by 24 h after injection. Fetal hyperglycemia reached a maximum by 72 h and persisted for at least 10 days after injection. Neonates delivered after fetal injection were frankly diabetic. Fetal STZ injection was associated with complete suppression of both glucose- and tolbutamide-stimulated insulin release, although no changes in peripheral insulin concentration were observed when compared with controls. Fetal pancreatic insulin content was only 13{\%} of that expected on the basis of gestational age. In a subgroup of 7 STZ-treated fetal lambs, fetal hyperglycemia was related to decrements in umbilical venoarterial difference of glucose, umbilical glucose uptake, and glucose-O2 quotient. No changes in maternal glucose homeostasis or in fetal O2 consumption were noted. The data suggest that deficient fetal insulin storage and secretion are associated with a decrement in exogenous fetal glucose entry but not in fetal metabolic rate. Whether the observed fetal changes relate to enhanced endogenous fetal glucose production with a passive decrease in maternofetal glucose transfer or are simply due to a decrease in overall fetal glucose utilization is not known. It is speculated that a quantitative decrease in pancreatic insulin secretion is responsible for the observed changes.",
author = "Philipps, {Anthony F} and Rosenkrantz, {T. S.} and Grunnet, {M. L.} and Connolly, {M. E.} and Porte, {P. J.} and Raye, {J. R.}",
year = "1986",
language = "English (US)",
volume = "35",
pages = "964--972",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "9",

}

TY - JOUR

T1 - Effects of fetal insulin secretory deficiency on metabolism in fetal lamb

AU - Philipps, Anthony F

AU - Rosenkrantz, T. S.

AU - Grunnet, M. L.

AU - Connolly, M. E.

AU - Porte, P. J.

AU - Raye, J. R.

PY - 1986

Y1 - 1986

N2 - Fetal insulin secretion may be of importance in determining both fetal metabolic rate and glucose homeostasis in the resting state. To investigate this question, streptozocin (STZ) was injected into 10 late-gestation fetal lambs, and the effects of STZ on fetal pancreatic insulin storage and secretion, fetal metabolic rate, and umbilical glucose uptake were then studied. Fetal STZ injection caused a relative fetal hyperglycemia by 24 h after injection. Fetal hyperglycemia reached a maximum by 72 h and persisted for at least 10 days after injection. Neonates delivered after fetal injection were frankly diabetic. Fetal STZ injection was associated with complete suppression of both glucose- and tolbutamide-stimulated insulin release, although no changes in peripheral insulin concentration were observed when compared with controls. Fetal pancreatic insulin content was only 13% of that expected on the basis of gestational age. In a subgroup of 7 STZ-treated fetal lambs, fetal hyperglycemia was related to decrements in umbilical venoarterial difference of glucose, umbilical glucose uptake, and glucose-O2 quotient. No changes in maternal glucose homeostasis or in fetal O2 consumption were noted. The data suggest that deficient fetal insulin storage and secretion are associated with a decrement in exogenous fetal glucose entry but not in fetal metabolic rate. Whether the observed fetal changes relate to enhanced endogenous fetal glucose production with a passive decrease in maternofetal glucose transfer or are simply due to a decrease in overall fetal glucose utilization is not known. It is speculated that a quantitative decrease in pancreatic insulin secretion is responsible for the observed changes.

AB - Fetal insulin secretion may be of importance in determining both fetal metabolic rate and glucose homeostasis in the resting state. To investigate this question, streptozocin (STZ) was injected into 10 late-gestation fetal lambs, and the effects of STZ on fetal pancreatic insulin storage and secretion, fetal metabolic rate, and umbilical glucose uptake were then studied. Fetal STZ injection caused a relative fetal hyperglycemia by 24 h after injection. Fetal hyperglycemia reached a maximum by 72 h and persisted for at least 10 days after injection. Neonates delivered after fetal injection were frankly diabetic. Fetal STZ injection was associated with complete suppression of both glucose- and tolbutamide-stimulated insulin release, although no changes in peripheral insulin concentration were observed when compared with controls. Fetal pancreatic insulin content was only 13% of that expected on the basis of gestational age. In a subgroup of 7 STZ-treated fetal lambs, fetal hyperglycemia was related to decrements in umbilical venoarterial difference of glucose, umbilical glucose uptake, and glucose-O2 quotient. No changes in maternal glucose homeostasis or in fetal O2 consumption were noted. The data suggest that deficient fetal insulin storage and secretion are associated with a decrement in exogenous fetal glucose entry but not in fetal metabolic rate. Whether the observed fetal changes relate to enhanced endogenous fetal glucose production with a passive decrease in maternofetal glucose transfer or are simply due to a decrease in overall fetal glucose utilization is not known. It is speculated that a quantitative decrease in pancreatic insulin secretion is responsible for the observed changes.

UR - http://www.scopus.com/inward/record.url?scp=0022460072&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022460072&partnerID=8YFLogxK

M3 - Article

C2 - 2943621

AN - SCOPUS:0022460072

VL - 35

SP - 964

EP - 972

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 9

ER -